AIM ImmunoTech Inc’s recently made public that its Director BRYAN NANCY acquired Company’s shares for reported $15000.0 on Mar 21 ’24. In the deal valued at $0.39 per share,38,462 shares were bought. As a result of this transaction, BRYAN NANCY now holds 38,462 shares worth roughly $16538.66.
Then, APPELROUTH STEWART bought 90,910 shares, generating $30,000 in total proceeds. Upon buying the shares at $0.33, the Director now owns 239,765 shares.
Before that, Equels Thomas K bought 75,758 shares. AIM ImmunoTech Inc shares valued at $25,000 were divested by the CEO & President at a price of $0.33 per share. As a result of the transaction, Equels Thomas K now holds 716,455 shares, worth roughly $0.31 million.
Price Performance Review of AIM
On Tuesday, AIM ImmunoTech Inc [AMEX:AIM] saw its stock jump 1.31% to $0.43. Over the last five days, the stock has lost -14.06%. AIM ImmunoTech Inc shares have fallen nearly -3.27% since the year began. Nevertheless, the stocks have fallen -16.32% over the past one year. While a 52-week high of $0.75 was reached on 04/11/24, a 52-week low of $0.32 was recorded on 03/14/24. SMA at 50 days reached $0.4311, while 200 days put it at $0.4968. A total of 0.26 million shares were traded, compared to the trading of 0.17 million shares in the previous session.
Levels Of Support And Resistance For AIM Stock
The 24-hour chart illustrates a support level at 0.3954, which if violated will result in even more drops to 0.3652. On the upside, there is a resistance level at 0.4603. A further resistance level may holdings at 0.4950. The Relative Strength Index (RSI) on the 14-day chart is 44.05, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0619, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.41%. Stochastics %K at 11.52% indicates the stock is a buying.
